This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
CubeSmart (CUBE) Beats Q2 FFO and Revenue Estimates
by Zacks Equity Research
CubeSmart (CUBE) delivered FFO and revenue surprises of +3.17% and +2.91%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Ventas (VTR) Beats Q2 FFO and Revenue Estimates
by Zacks Equity Research
Ventas (VTR) delivered FFO and revenue surprises of +2.35% and +3.47%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Is Diversified Healthcare Trust (DHC) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Fast-paced Momentum Stock Diversified Healthcare (DHC) Is Still Trading at a Bargain
by Zacks Equity Research
Diversified Healthcare (DHC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Should Value Investors Buy Diversified Healthcare Trust (DHC) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Fast-paced Mover Diversified Healthcare (DHC) Is a Great Choice for Value Investors
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Diversified Healthcare (DHC) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
After Golden Cross, Diversified Healthcare (DHC)'s Technical Outlook is Bright
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
Are Investors Undervaluing Diversified Healthcare Trust (DHC) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Despite Fast-paced Momentum, Diversified Healthcare (DHC) Is Still a Bargain Stock
by Zacks Equity Research
Diversified Healthcare (DHC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Diversified Healthcare (DHC) Misses Q3 FFO and Revenue Estimates
by Zacks Equity Research
Diversified Healthcare (DHC) delivered FFO and revenue surprises of -60% and 0.84%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Diversified Healthcare (DHC) Matches Q2 FFO Estimates
by Zacks Equity Research
Diversified Healthcare (DHC) delivered FFO and revenue surprises of 0% and 0.19%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Fast-paced Momentum Stock Diversified Healthcare (DHC) Is Still Trading at a Bargain
by Zacks Equity Research
Diversified Healthcare (DHC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Why Fast-paced Mover Diversified Healthcare (DHC) Is a Great Choice for Value Investors
by Zacks Equity Research
Diversified Healthcare (DHC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Diversified Healthcare (DHC) Q1 FFO Match Estimates
by Zacks Equity Research
Diversified Healthcare (DHC) delivered FFO and revenue surprises of 0% and 0.17%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for April 26th
by Zacks Equity Research
AMPH, BCML and DHC have been added to the Zacks Rank #5 (Strong Sell) List on April 26, 2024.
New Strong Sell Stocks for April 24th
by Zacks Equity Research
BABA, TCPC and DHC have been added to the Zacks Rank #5 (Strong Sell) List on April 24, 2024.
Should Schwab Fundamental U.S. Small Company Index ETF (FNDA) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FNDA
Diversified Healthcare Trust (DHC) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Diversified Healthcare Trust (DHC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Why Diversified Healthcare (DHC) Dipped More Than Broader Market Today
by Zacks Equity Research
Diversified Healthcare (DHC) closed at $2.59 in the latest trading session, marking a -1.15% move from the prior day.
Diversified Healthcare Trust (DHC) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Diversified Healthcare (DHC). This makes it worthwhile to examine what the stock has in store.
Diversified Healthcare Trust (DHC) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
Zacks.com users have recently been watching Diversified Healthcare (DHC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Is Schwab Fundamental U.S. Small Company Index ETF (FNDA) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FNDA
Diversified Healthcare (DHC) Q4 FFO and Revenues Lag Estimates
by Zacks Equity Research
Diversified Healthcare (DHC) delivered FFO and revenue surprises of -40% and 0.21%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Diversified Healthcare (DHC) Advances While Market Declines: Some Information for Investors
by Zacks Equity Research
In the most recent trading session, Diversified Healthcare (DHC) closed at $3.01, indicating a +1.69% shift from the previous trading day.
Investors Heavily Search Diversified Healthcare Trust (DHC): Here is What You Need to Know
by Zacks Equity Research
Recently, Zacks.com users have been paying close attention to Diversified Healthcare (DHC). This makes it worthwhile to examine what the stock has in store.